<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>4</IssueIDStart>
          <IssueIDEnd>4</IssueIDEnd>
          <IssueArticleCount>15</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>12</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2006</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art6">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>74847</ArticleID>
            <ArticleDOI>10.1208/aapsj070481</ArticleDOI>
            <ArticleSequenceNumber>6</ArticleSequenceNumber>
            <ArticleTitle Language="En">Role of monoamine transporters in mediating psychostimulant effects</ArticleTitle>
            <ArticleFirstPage>E847</ArticleFirstPage>
            <ArticleLastPage>E851</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>8</Month>
                <Day>26</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>9</Month>
                <Day>12</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>4</IssueIDStart>
              <IssueIDEnd>4</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Evan</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Riddle</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Annette</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Fleckenstein</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Glen</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Hanson</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(801) 581-3174</Phone>
                  <Fax>(801) 585-5111</Fax>
                  <Email>glen.hanson@pharm.utah.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Pharmacology and Toxicology</OrgDivision>
                <OrgName>University of Utah</OrgName>
                <OrgAddress>
                  <Street>30 South 2000 East, Room 201</Street>
                  <Postcode>84112</Postcode>
                  <City>Salt Lake City</City>
                  <State>Utah</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Monoamine transporters such as the dopamine (DA) transporter (DAT) and the vesicular monoamine transporter-2 (VMAT-2) are critical regulators of DA disposition within the brain. Alterations in DA disposition can lead to conditions such as drug addiction, Parkinson’s disease, and schizophrenia, a fact that underscores the importance of understanding DAergic signaling. Psychostimulants alter DAergic signaling by influencing both DAT and VMAT-2, and although the effects of these drugs result in increased levels of synaptic DA, the mechanisms by which this occurs and the effects that these drugs exert on DAT and VMAT-2 vary. Many psychostimulants can be classified as releasers (ie, amphetamine analogs) or uptake blockers (ie, cocaine-like drugs) based on the mechanism of their acute effects on neurotransmitter flux through the DAT. Releasers and uptake blockers differentially modulate the activity and subcellular distribution of monoamine transporters, a phenomenon likely related to the neurotoxics potential of these drugs to DAergic neurons. This article will review some of the recent findings whereby releasers and uptake blockers alter DAT and VMAT-2 activity and how these alterations may be involved in neurotoxicity, thus providing insight on the neuro-degeneration observed in Parkinson’s disease.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>dopamine transporter</Keyword>
              <Keyword>vesicular monoamine transporter-2</Keyword>
              <Keyword>amphetamine</Keyword>
              <Keyword>cocaine</Keyword>
              <Keyword>methylphenidate</Keyword>
              <Keyword>Parkinson’s disease</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: December 20, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_74847.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Butcher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Liptrot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GW</Initials>
                    <FamilyName>Aburthnott</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo microdialysis</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>122</VolumeID>
                  <FirstPage>245</FirstPage>
                  <LastPage>248</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1902922</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0304-3940(91)90869-U</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXhsFOjtLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Butcher SP, Liptrot J, Aburthnott GW. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo microdialysis.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1991;122:245–248.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Russell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Viliers</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sagvolden</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lamm</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Taljaard</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Differences between electrically-, Ritalin-, and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired storage of dopamine in an animal model of attention-deficit hyperactivity disorder</ArticleTitle>
                  <JournalTitle>Behav Brain Res</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <FirstPage>163</FirstPage>
                  <LastPage>171</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9708847</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0166-4328(97)00177-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjs1arsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Russell V, de Viliers A, Sagvolden T, Lamm M, Taljaard J. Differences between electrically-, Ritalin-, and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired storage of dopamine in an animal model of attention-deficit hyperactivity disorder.<Emphasis Type="Italic">Behav Brain Res</Emphasis>. 1998;94:163–171.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Horn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Coyle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Snyder</FamilyName>
                  </BibAuthorName>
                  <Year>1971</Year>
                  <ArticleTitle Language="En">Catecholamine uptake by synaptosomes from rat brain: structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>66</FirstPage>
                  <LastPage>80</LastPage>
                  <Occurrence Type="PID">
                    <Handle>5552252</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE3MXosF2ntA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Horn AS, Coyle JT, Snyder SH. Catecholamine uptake by synaptosomes from rat brain: structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1971;7:66–80.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KA</Initials>
                    <FamilyName>Hogan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Staal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PK</Initials>
                    <FamilyName>Sonsalla</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>2217</FirstPage>
                  <LastPage>2220</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10800969</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2000.0742217.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXis12qsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hogan KA, Staal RG, Sonsalla PK. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2000;74:2217–2220.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Eyerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BK</Initials>
                    <FamilyName>Yamamoto</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>312</VolumeID>
                  <FirstPage>160</FirstPage>
                  <LastPage>169</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15331654</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.104.072264</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVWmtL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eyerman DJ, Yamamoto BK. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2005;312:160–169.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Riddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Sandoval</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">A single methamphetamine administration rapidly decreases vesicular dopamine uptake</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>302</VolumeID>
                  <FirstPage>497</FirstPage>
                  <LastPage>501</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12130707</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.302.2.497</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xls1Ogsbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brown JM, Riddle EL, Sandoval V, et al. A single methamphetamine administration rapidly decreases vesicular dopamine uptake.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;302:497–501.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Riddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MK</Initials>
                    <FamilyName>Topham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Haycock</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>449</VolumeID>
                  <FirstPage>71</FirstPage>
                  <LastPage>74</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12163108</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(02)01985-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmtVWlt7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2002;449:71–74.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Sandoval</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Riddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>8705</FirstPage>
                  <LastPage>8710</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12351745</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xns1CisL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:8705–8710.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HK</Initials>
                    <FamilyName>Wayment</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Deutsch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Schweri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JO</Initials>
                    <FamilyName>Schenk</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>1266</FirstPage>
                  <LastPage>1274</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10037500</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.1999.0721266.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhsFWgsbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wayment HK, Deutsch H, Schweri MM, Schenk JO. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1999;72:1266–1274.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Ritz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Lamb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Goldberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Kuhar</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Cocaine receptors on dopamine transporters are related to self-administration of cocaine</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>237</VolumeID>
                  <FirstPage>1219</FirstPage>
                  <LastPage>1223</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2820058</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.2820058</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXls1yisr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine.<Emphasis Type="Italic">Science</Emphasis>. 1987;237:1219–1223.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SY</Initials>
                    <FamilyName>Yeh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EB</Initials>
                    <FamilyName>Souza</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons</ArticleTitle>
                  <JournalTitle>Drug Alcohol Depend</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>51</FirstPage>
                  <LastPage>61</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1709403</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0376-8716(91)90086-E</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXhsl2rsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yeh SY, De Souza EB. Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons.<Emphasis Type="Italic">Drug Alcohol Depend</Emphasis>. 1991;27:51–61.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HM</Initials>
                    <FamilyName>Haughey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RR</Initials>
                    <FamilyName>Metzger</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol.</JournalTitle>
                  <VolumeID>382</VolumeID>
                  <FirstPage>45</FirstPage>
                  <LastPage>49</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10556503</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(99)00588-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXntVCnsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fleckenstein AE, Haughey HM, Metzger RR, et al. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1999;382:45–49.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LC</Initials>
                    <FamilyName>Daws</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PD</Initials>
                    <FamilyName>Callaghan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Moron</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Cocaine increases dopamine uptake and cell surface expression of dopamine transporters</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>290</VolumeID>
                  <FirstPage>1545</FirstPage>
                  <LastPage>1550</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11820798</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2002.6384</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XotlKruw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Daws LC, Callaghan PD, Moron JA, et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2002;290:1545–1550.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>Mash</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Pablo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Ouyang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WL</Initials>
                    <FamilyName>Hearn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Izenwasser</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Dopamine transport function is elevated in cocaine users</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>81</VolumeID>
                  <FirstPage>292</FirstPage>
                  <LastPage>300</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12064476</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2002.00820.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xjt1Cjtrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2002;81:292–300.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Sandoval</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Riddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>1181</FirstPage>
                  <LastPage>1187</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12604695</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.045005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXit1eis7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:1181–1187.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>1150</FirstPage>
                  <LastPage>1153</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11504813</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmtFKmtL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brown JM, Hanson GR, Fleckenstein AE. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:1150–1153.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Truong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KS</Initials>
                    <FamilyName>Rau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Fleckenstein. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson’s neurodegeneration</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>474</VolumeID>
                  <FirstPage>223</FirstPage>
                  <LastPage>226</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12921866</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(03)02080-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmt1Kju7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Truong JG, Rau KS, Hanson GR. Fleckenstein. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson’s neurodegeneration.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2003;474: 223–226.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Truong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>492</VolumeID>
                  <FirstPage>143</FirstPage>
                  <LastPage>147</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15178358</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2004.03.060</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkslWrsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Truong JG, Hanson GR, Fleckenstein AE. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004<Emphasis Type="Italic">a</Emphasis>,492:143–147.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Truong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Newman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>504</VolumeID>
                  <FirstPage>27</FirstPage>
                  <LastPage>32</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15507217</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2004.09.049</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXovFans7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Truong JG, Newman AH, Hanson GR, Fleckenstein AE. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004<Emphasis Type="Italic">b</Emphasis>;504:27–32.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Sulzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rayport</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Am phetamine and other psychostimulants reduce pH gradients in midbrain dopamine neurons and chromaffin granules: a mechanism of action</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>797</FirstPage>
                  <LastPage>808</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2268433</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0896-6273(90)90339-H</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXhvF2msr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sulzer D, Rayport S. Am phetamine and other psychostimulants reduce pH gradients in midbrain dopamine neurons and chromaffin granules: a mechanism of action.<Emphasis Type="Italic">Neuron</Emphasis>. 1990;5:797–808.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Sulzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TK</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YY</Initials>
                    <FamilyName>Lau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kristensen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rayport</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ewing</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>4102</FirstPage>
                  <LastPage>4108</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7751968</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXls1aitrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1995;15:4102–4108.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NY</Initials>
                    <FamilyName>Liang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CO</Initials>
                    <FamilyName>Rutledge</FamilyName>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Evidence for carrier-mediated efflux of dopamine from corpus striatum</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>2479</FirstPage>
                  <LastPage>2484</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7126258</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-2952(82)90057-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3sXivVChsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liang NY, Rutledge CO. Evidence for carrier-mediated efflux of dopamine from corpus striatum.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1982;31:2479–2484.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Kahlig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Binda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Khoshbouei</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Amphetamine induces dopamine efflux through a dopamine transporter channel</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>102</VolumeID>
                  <FirstPage>3495</FirstPage>
                  <LastPage>3500</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15728379</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0407737102</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXitl2ksro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kahlig KM, Binda F, Khoshbouei H, et al. Amphetamine induces dopamine efflux through a dopamine transporter channel.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis> 2005;102:3495–3500.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RR</Initials>
                    <FamilyName>Metzger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Gibb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">A rapid and reversible change in dopamine transporters induced by metham phetamine</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>323</VolumeID>
                  <FirstPage>R9</FirstPage>
                  <LastPage>10</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9128855</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(97)00148-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXitVKktb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fleckenstein AE, Metzger RR, Gibb JW, Hanson GR. A rapid and reversible change in dopamine transporters induced by metham phetamine.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1997;323:R9–10.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Saunders</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JV</Initials>
                    <FamilyName>Ferrer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Shi</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine sensitive mechanism</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>6850</FirstPage>
                  <LastPage>6855</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10823899</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.110035297</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXktFahsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Saunders C, Ferrer JV, Shi L, et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine sensitive mechanism.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2000;97:6850–6855.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Gibb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hanson</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>406</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>13</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11011026</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(00)00639-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmslOit7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fleckenstein AE, Gibb JW, Hanson GR. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;406:1–13.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Baucum</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KS</Initials>
                    <FamilyName>Rau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Riddle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GR</Initials>
                    <FamilyName>Hansons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fleckenstein</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine-and hyperthermia-associated mechanisms</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>3436</FirstPage>
                  <LastPage>3443</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15056723</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1523/JNEUROSCI.0387-04.2004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjt1yhsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baucum AJ, Rau KS, Riddle EL, Hansons GR, Fleckenstein AE. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine-and hyperthermia-associated mechanisms.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2004;24:3436–3443.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibUnstructured>Baucum AJ, Cook GA, Hanson JE, Hanson GR, Fleckenstein AE. Reactive oxygen species contribute to dopamine transporter oligomerization [abstract].<Emphasis Type="Italic">Exp Biol.</Emphasis> 2005; Abstract 312.6.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Cubells</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rayport</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Rajendran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Sulzer</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress</ArticleTitle>
                  <JournalTitle>J Neurosci.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>2260</FirstPage>
                  <LastPage>2271</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8158268</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXkslemsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cubells JF, Rayport S, Rajendran G, Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1994;14:2260–2271.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Marek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Vosmer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LS</Initials>
                    <FamilyName>Seiden</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons</ArticleTitle>
                  <JournalTitle>Brain Res</JournalTitle>
                  <VolumeID>517</VolumeID>
                  <FirstPage>274</FirstPage>
                  <LastPage>279</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-8993(90)90467-P</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marek GJ, Vosmer G, Seiden LS. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.<Emphasis Type="Italic">Brain Res</Emphasis>. 1990;517:274–279.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
